Clariant ‘REACh’ phase one

25 January 2011

Global leather chemical makers Clariant are now focusing on phase two of REACh legislation following its successful completion of the registration of 152 substances required under phase one by the December 1, 2010 deadline. Phase two, which concerns more than 300 chemicals, should be completed by June 1, 2013. For Phase One, the company held a unique position in leading 81 out of 152 (> 50%) consortia and Substance Information Exchange Forums (SIEFs). The phase one substances covered finished products, intermediates and raw materials across eight of their business units.

Due to the extensive knowledge and expertise of the toxicological, ecotoxicological and physical chemical properties of our substances Clariant took over the lead function for the majority of the respective consortia. Their REACh registration teams comprising of product stewardship specialists, toxicologists, ecotoxicologists, lawyers and IT specialists.

‘We are delighted to have completed the task assigned to us’, comments Hariolf Kottmann, CEO Clariant. ‘Our achievement in completing phase one registration inside the deadline required a lot of long, hard work, and an intensive use of resources. Customers have expressed their appreciation for our dedication in supporting their efforts to be REACh compliant when using our materials in their products and formulations.’ Complying with REACh is a prerequisite for a company’s ability to operate in Europe. Any substances not registered by the deadlines set for each phase will not be allowed to be produced, imported or sold, as clearly stated in Article 5 of the REACh regulations.

Phase two is concerned with the registration of substances supplied at ≥ 100 t/a by June 1, 2013. Clariant have several hundreds chemicals that fall under this category.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.